We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Apple
AAPL
|
+$75.7M |
| 3 |
Tesla
TSLA
|
+$70.4M |
| 4 |
Amazon
AMZN
|
+$65M |
| 5 |
Procter & Gamble
PG
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$21.1M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Revolution Medicines
RVMD
$44B
| $2.13M | ﹤0.01% |
108,102
+17,199
| +19% | +$378K |
|
1727
QuantumScape Corp
QS
$3.74B
| $2.12M | ﹤0.01% |
252,510
+24,155
| +11% | +$259K |
|
1728
Matthews International
MATW
$739M
| $2.12M | ﹤0.01% |
94,694
+1,849
| +2% | +$48.1K |
|
|
ATSG
1729
DELISTED
Air Transport Services Group
ATSG
| $2.12M | ﹤0.01% |
87,947
+5,209
| +6% | +$151K |
|
|
HA
1730
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.12M | ﹤0.01% |
161,128
+7,479
| +5% | +$114K |
|
1731
Hawkins
HWKN
$2.71B
| $2.12M | ﹤0.01% |
54,248
+2,018
| +4% | +$78.2K |
|
1732
BRC Group Holdings
RILY
$289M
| $2.11M | ﹤0.01% |
47,483
+1,638
| +4% | +$81.9K |
|
1733
Frontline
FRO
$8.85B
| $2.11M | ﹤0.01% |
193,040
+13,597
| +8% | +$149K |
|
1734
Scansource
SCSC
$1.12B
| $2.1M | ﹤0.01% |
79,720
+263
| +0.3% | +$7.95K |
|
|
NVRO
1735
DELISTED
NEVRO CORP.
NVRO
| $2.09M | ﹤0.01% |
44,778
+3,335
| +8% | +$155K |
|
|
PENG
1736
Penguin Solutions Inc
PENG
$2.99B
| $2.08M | ﹤0.01% |
131,254
+9,287
| +8% | +$169K |
|
1737
Metallus
MTUS
$898M
| $2.08M | ﹤0.01% |
138,881
+3,948
| +3% | +$65.8K |
|
1738
Asana
ASAN
$2.13B
| $2.08M | ﹤0.01% |
93,628
+7,641
| +9% | +$164K |
|
1739
G-III Apparel Group
GIII
$1.5B
| $2.08M | ﹤0.01% |
138,875
+5,463
| +4% | +$112K |
|
|
INVX
1740
Innovex International
INVX
$1.97B
| $2.07M | ﹤0.01% |
106,136
+2,877
| +3% | +$66.7K |
|
1741
Cytek Biosciences
CTKB
$546M
| $2.07M | ﹤0.01% |
140,718
+11,751
| +9% | +$153K |
|
|
RPT
1742
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.07M | ﹤0.01% |
273,644
+7,484
| +3% | +$73.6K |
|
1743
Haverty Furniture Companies
HVT
$454M
| $2.06M | ﹤0.01% |
82,674
+37,834
| +84% | +$1.02M |
|
|
EVOP
1744
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.05M | ﹤0.01% |
61,586
+7,693
| +14% | +$238K |
|
1745
Cohen & Steers
CNS
$4.3B
| $2.05M | ﹤0.01% |
32,724
+2,368
| +8% | +$169K |
|
1746
Pacific Biosciences
PACB
$370M
| $2.05M | ﹤0.01% |
352,808
+23,329
| +7% | +$134K |
|
1747
John B. Sanfilippo & Son
JBSS
$972M
| $2.04M | ﹤0.01% |
26,926
+702
| +3% | +$53.1K |
|
1748
Mueller Water Products
MWA
$4.16B
| $2.03M | ﹤0.01% |
197,752
+14,107
| +8% | +$164K |
|
1749
Comstock Resources
CRK
$3.94B
| $2.03M | ﹤0.01% |
117,382
+9,460
| +9% | +$157K |
|
1750
Peloton Interactive
PTON
$2.49B
| $2.03M | ﹤0.01% |
292,617
+26,497
| +10% | +$269K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.
- RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
- RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
- RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
- RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
- RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
- RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.